CX 2019 Presentations
Please note: Some presentations may not be available as permission may not have been given to publish. Sometimes this will include a debate session, during which one speaker has given permission but another speaker has denied it, resulting in the entire session not being uploaded to the website.
Peripheral Proximal Arterial Ischaemia Challenges - Tuesday, 16th April
Venue: Upper Main Auditorium
Time: 08:00 - 18:00
Imaging
Chairing: | Robert Morgan, President CIRSE, London, United Kingdom |
Moderator: | Andrew Holden, Auckland, New Zealand |
Paclitaxel: The last word
Chairing: | Roger Greenhalgh, London, United Kingdom |
Moderators: | Andrew Holden, Auckland, New Zealand |
Gunnar Tepe, Rosenheim, Germany | |
Thomas Zeller, Bad Krozingen, Germany |
Review of paclitaxel usage: The way forward
Chairing: | Roger Greenhalgh, London, United Kingdom |
Moderators: | Andrew Holden, Auckland, New Zealand |
Gunnar Tepe, Rosenheim, Germany | |
Thomas Zeller, Bad Krozingen, Germany |
Time: 16:00 - 16:30
Edited case: Treating iliac occlusive disease with a covered endoprosthesis - Tuesday, 16th April
Case presenter: | Andrew Holden, Auckland, New Zealand |
Time: 17:45 - 17:50
CX Debate: In the absence of suitable venous graft material prosthetic bypass is the answer - Tuesday, 16th April
Against the motion
Time: 17:45 - 17:50
Andrew Holden, Auckland, New Zealand | |
CLICK HERE TO VIEW VIDEO |
Peripheral Critical Ischaemia Challenges - Thursday, 18th April
Venue: Lower Main Auditorium
Time: 08:00 - 18:00
Time: 10:46 - 10:54
Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry - Thursday, 18th April
Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 11:22 - 11:30
Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms - Thursday, 18th April
Speaker: | Andrew Holden, Auckland, New Zealand |
Thoracic Aortic Challenges - Thursday, 18th April
Venue: Upper Main Auditorium
Time: 08:00 - 18:00
Radiation
Chairing: | Dittmar Böckler, President DGG, Heidelberg, Germany |
Moderator: | Andrew Holden, Auckland, New Zealand |
CX Vascular Access Masterclass - Wednesday, 17th April
Venue: Pillar Hall Learning Centre
Time: 08:00 - 17:42
Time: 14:49 - 14:57
IN.PACT AV: Baseline data from the full cohort - Wednesday, 17th April
Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 14:57 - 15:17
DCBs: Is the data on PVD applicable to vascular access? - Wednesday, 17th April
Panel: | Andrew Holden, Auckland, New Zealand |
CX Innovation Showcase - Thursday, 18th April
Venue: Pillar Hall Learning Centre
Time: 07:30 - 18:00
Time: 09:40 - 09:50
Temporary drug-coated Spur system to address the challenges of DCB technology - Thursday, 18th April
Speaker: | Andrew Holden, Auckland, New Zealand |
Diagnostic and imaging innovation - Thursday, 18th April
Time: 16:00 - 16:40
Chairing: | Andrew Holden, Auckland, New Zealand |
Moderator: | Stephen Greenhalgh, London, United Kingdom |
Dragons' Den - Thursday, 18th April
Time: 16:55 - 18:05
Panel: | Andrew Holden, Auckland, New Zealand |
Bob Mitchell, Irvine, United States | |
Peter Phillips, Didcot, United Kingdom | |
Chas Taylor, Horsham, United Kingdom | |
Jeffrey Jump, Mont-sur-Rolle, Switzerland | |
Alan Edwards, Ruthin, United Kingdom | |
Frans Moll, Utrecht, Netherlands |
CX Peripheral Techniques & Technologies (live & edited cases) - Wednesday, 17th April
Venue: Lower Main Auditorium
Time: 09:30 - 18:00
Time: 10:17 - 10:24
Optimised treatment strategies for post-PTA dissection - Wednesday, 17th April
Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 11:00 - 11:30
Edited case: Drug-coated balloon in AV access - Wednesday, 17th April
Speaker: | Andrew Holden, Auckland, New Zealand |
Peripheral Arterial Podium 1st Session - Thursday, 18th April
Venue: Lower Main Auditorium
Time: 10:30 - 12:30
Time: 10:46 - 10:54
Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry - Thursday, 18th April
Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 11:22 - 11:30
Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms - Thursday, 18th April
Speaker: | Andrew Holden, Auckland, New Zealand |